NCLT Mumbai Approves Merger of Arrka Infosec Private Limited with Persistent Systems Limited

3 min read     Updated on 12 May 2026, 05:30 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

NCLT Mumbai Bench-I approved the amalgamation of Arrka Infosec Private Limited with Persistent Systems Limited under Sections 230–232 of the Companies Act, 2013. The certified copy of the order was received on May 11, 2026, following the order pronounced on April 21, 2026, with an appointed date of April 1, 2025. The merger aims to simplify corporate structure, achieve synergy gains, and reduce administrative costs, with no new shares to be allotted as Arrka Infosec is a wholly owned subsidiary of Persistent Systems.

powered bylight_fuzz_icon
40053739

*this image is generated using AI for illustrative purposes only.

Persistent Systems Limited has received the Certified True Copy of the order issued by the Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench-I, approving the Scheme of Amalgamation of its wholly owned subsidiary, Arrka Infosec Private Limited (Transferor Company), with Persistent Systems Limited (Transferee Company). The certified copy was received through the company's advocate on May 11, 2026, following the order pronounced on April 21, 2026.

Key Details of the Merger Order

The merger was adjudicated under Company Petition CP (CAA) No. 206/MB/2025 in CA (CAA) No. 179/MB/2025, before a bench comprising Shri Prabhat Kumar, Member (Technical), and Shri Sushil Mahadeorao Koche, Member (Judicial). The following table summarises the key parameters of the approved scheme:

Parameter: Details
Transferor Company: Arrka Infosec Private Limited
Transferee Company: Persistent Systems Limited
Order Pronounced On: April 21, 2026
Certified Copy Received On: May 11, 2026
Appointed Date: April 1, 2025
Petition Number: CP (CAA) No. 206/MB/2025 in CA (CAA) No. 179/MB/2025
Governing Provisions: Sections 230–232, Companies Act, 2013

Background of the Petitioner Companies

Arrka Infosec Private Limited (CIN: U72200PN2012PTC141873) was originally incorporated on January 6, 2012, under the name "Innovative 21st Century Technologies Minds Private Limited" and was subsequently renamed on July 14, 2017. The company is engaged in information technology and IT-enabled services, including data processing, analytics, strategic management, and HR analytics, among others. Its registered office is located at Bhageerath, Vetal Chowk, 402E, Senapati Bapat Road, Pune 411016, and it is a wholly owned subsidiary of Persistent Systems Limited.

Persistent Systems Limited (CIN: L72300PN1990PLC056696) was incorporated on May 30, 1990, and is engaged in the design, development, manufacture, and marketing of computer software, firmware, and hardware systems for commercial, industrial, scientific, medical, and defence applications. Its registered office is at Bhageerath, 402 Senapati Bapat Road, Pune, Maharashtra, India, 411016. The shares of Persistent Systems Limited are listed on BSE and NSE, while those of Arrka Infosec Private Limited are not listed on any stock exchange.

Rationale for the Scheme

The Board of Directors of both companies approved the scheme — Arrka Infosec on April 24, 2025, and Persistent Systems on April 23, 2025. The rationale cited for the amalgamation includes:

  • Simplification of the corporate structure by merging a wholly owned subsidiary operating in a similar line of business
  • Realisation of synergy gains and elimination of duplicate corporate procedures
  • Consolidation of undertakings for effective management and unified control of operations
  • Reduction of administrative and managerial costs, and minimisation of duplication of records and regulatory compliances

Consideration and Capital Treatment

Since Arrka Infosec Private Limited is a wholly owned subsidiary of Persistent Systems Limited, no new shares of the Transferee Company will be allotted in lieu of or in exchange for the holding in the Transferor Company. Upon the scheme becoming effective, the issued and paid-up capital of the Transferor Company shall stand cancelled on the Effective Date without any further act, instrument, or deed.

Regulatory Compliance and Key Directions

The NCLT noted that all requisite statutory compliances had been fulfilled and that no objections were received from any statutory, regulatory authority, creditors, members, or other stakeholders. The Official Liquidator, High Court, Bombay, confirmed in its report dated January 8, 2026, that the affairs of the Transferor Company had not been conducted in a manner prejudicial to the interests of creditors or to public interest. The Income Tax Department, which had initially raised observations, conveyed on January 9, 2026, that it had no objection to the scheme, subject to protection of its rights.

Key directions issued by the NCLT include:

  • The Petitioner Companies must file a copy of the order along with the Scheme with the concerned Registrar of Companies electronically in E-Form INC-28 within 30 days from the date of receipt of the order
  • A copy of the order and scheme must be lodged with the concerned Superintendent of Stamps for adjudication of stamp duty within 60 days from receipt of the order
  • All employees of the Transferor Company in service on the date immediately preceding the Effective Date shall become employees of Persistent Systems Limited without any break or interruption in service, on terms and conditions not less favourable than those subsisting prior to the merger
  • The Transferor Company is dissolved without winding up upon the scheme taking effect
  • All liabilities of the Transferor Company shall be transferred to Persistent Systems Limited; liabilities in respect of offences committed prior to the merger shall continue as provided under Section 240 of the Companies Act, 2013

Historical Stock Returns for Persistent Systems

1 Day5 Days1 Month6 Months1 Year5 Years
-0.93%-0.95%+5.21%-20.23%-7.93%+318.64%

How will the absorption of Arrka Infosec's cybersecurity and data analytics capabilities strengthen Persistent Systems' competitive positioning against larger IT peers in winning enterprise security contracts?

Could this merger signal a broader consolidation strategy by Persistent Systems to absorb other wholly owned subsidiaries, and which entities in its corporate structure might be next candidates for amalgamation?

What measurable impact on operating margins and earnings per share can investors expect once the administrative cost savings and elimination of duplicate compliances from this merger are fully reflected in Persistent Systems' financials?

Persistent Systems Achieves Databricks BrickBuilder Specialization for Healthcare & Life Sciences

3 min read     Updated on 08 May 2026, 09:04 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Persistent Systems announced on May 7, 2026, that it has achieved the Databricks Brickbuilder Specialization for Healthcare and Life Sciences, validating its ability to deliver governed, production-grade data and AI solutions on the Databricks Data Intelligence platform. As a Silver Tier Global Systems Integrator partner with over 900 certifications, Persistent Systems leverages Delta Lake, Unity Catalog, and Mosaic AI to help HLS organizations unify multimodal data, accelerate clinical workflows, and operationalize AI at scale across regulated environments.

powered bylight_fuzz_icon
39684497

*this image is generated using AI for illustrative purposes only.

Persistent Systems , a global Digital Engineering and Enterprise Modernization leader, announced on May 7, 2026, that it has achieved the Databricks Brickbuilder Specialization for Healthcare and Life Sciences (HLS). This recognition validates Persistent Systems' ability to deliver production-grade, governed data and AI solutions on the Databricks Data Intelligence platform. The achievement strengthens the company's standing in serving providers, payers, pharmaceutical, biotechnology, and medical device organizations seeking to accelerate clinical development, improve patient outcomes, and operationalize AI across regulated environments.

Addressing HLS Data Challenges

HLS organizations face mounting pressure to accelerate clinical trials, shorten drug discovery timelines, and generate real-world evidence. Legacy architectures have historically struggled to integrate diverse datasets spanning clinical records, genomics, imaging, and patient data. Persistent Systems leverages the Databricks Data Intelligence platform to unify these data sources into a governed, AI-ready foundation, enabling improved trial design, faster cohort identification, biomarker discovery, and scalable evidence platforms.

The following core Databricks technologies underpin these solutions:

Technology: Role
Delta Lake Provides a reliable data foundation for AI and compliance
Unity Catalog Enables intelligent governance to monitor data and drive trusted insights
Mosaic AI Supports secure model development and deployment across use cases such as patient risk prediction, clinical trial optimization, and pharmacovigilance

Production-Grade, Regulatory-Compliant Solutions

Building on this foundation, Persistent Systems delivers production-grade, regulatory-compliant data and AI solutions tailored for HLS environments. These solutions are designed to move organizations from isolated pilots to enterprise-scale AI, ensuring accuracy, governance, and interoperability across clinical, R&D, commercial, and operational workflows. Real-world implementations include helping a Contract Research Organization improve trial success rates and supporting a Scientific Instruments and Medical Devices leader to accelerate innovation using the Databricks platform.

Partnership Credentials and Collaboration

Persistent Systems is a Global Systems Integrator partner for Databricks at the Silver Tier, with more than 900 certifications and a growing portfolio of accelerators on the Databricks Data Intelligence platform. The collaboration between Persistent Systems and Databricks continues to expand through co-creation and go-to-market initiatives focused on delivering measurable business outcomes across the HLS ecosystem.

Leadership Perspectives

Senior leaders from both Persistent Systems and Databricks highlighted the significance of the specialization:

  • Ganesh Nathella, Executive Vice President and General Manager – HLS Business, Persistent Systems, noted that the priority for HLS organizations is shifting from simply accessing data to making it actionable across clinical, research, and operational environments, and that the specialization reflects progress in building capabilities to address this shift.
  • Sameer Dixit, Corporate Vice President – Data, AI & Integration, Persistent Systems, emphasized that data readiness is critical to scaling AI in healthcare and life sciences, and that the specialization underscores the strength of the Persistent Systems–Databricks partnership.
  • Josh Meyer, Global Head of Partner Solutions and Industry GTM, Databricks, stated that Persistent Systems' achievement reflects their proven ability to turn data and AI into real-world impact, applying the Databricks platform to complex HLS challenges ranging from clinical insights to AI-driven drug discovery.

About Persistent Systems

Persistent Systems is a global services and solutions company delivering AI-led, platform-driven Digital Engineering and Enterprise Modernization to businesses across industries. With over 27,500 employees located in 18 countries, the company offers a comprehensive suite of services including software engineering, product development, data and analytics, CX transformation, cloud computing, and intelligent automation. The company has achieved carbon neutrality and has been named one of America's Greatest Workplaces for Inclusion & Diversity 2025 by Newsweek and Plant A Insights Group. With 468% growth in brand value since 2020, Persistent Systems is recognized as the fastest-growing IT services brand in the Brand Finance India 100 2025 Report.

Historical Stock Returns for Persistent Systems

1 Day5 Days1 Month6 Months1 Year5 Years
-0.93%-0.95%+5.21%-20.23%-7.93%+318.64%

How might Persistent Systems' Databricks Brickbuilder Specialization position it to compete for large-scale FDA-regulated AI deployment contracts against established HLS technology incumbents?

Could this specialization accelerate Persistent Systems' path toward achieving a higher Databricks partnership tier, and what additional capabilities or certifications would that require?

As AI-driven drug discovery becomes more mainstream, how might regulatory bodies like the FDA evolve their frameworks to govern the kind of production-grade AI solutions Persistent Systems is deploying?

More News on Persistent Systems

1 Year Returns:-7.93%